Endo (Nasdaq: ENDP) has reached an agreement with Watson Pharmaceuticals (NYSE: WPI) resolving two patent infringement lawsuits related to LIDODERM ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE